Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
about
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
description
clinical trial
@en
klinisch onderzoek
@nl
name
Lenalidomide Plus Rituximab Fo ...... Zone or Mantle Cell Lymphoma.
@en
type
label
Lenalidomide Plus Rituximab Fo ...... Zone or Mantle Cell Lymphoma.
@en
prefLabel
Lenalidomide Plus Rituximab Fo ...... Zone or Mantle Cell Lymphoma.
@en
P4844
P6153
P1050
P131
P1476
A Phase 3B Randomized Study of ...... Zone, or Mantle Cell Lymphoma
@en
P1813
MAGNIFY
@en
P3098
NCT01996865
P580
2014-04-02T00:00:00Z
P582
2023-04-08T00:00:00Z